oral semaglutide cost-benefit
Is Semaglutide Winning Over Obesity Treatment Clinics?
The FDA has excluded three GLP-1 drugs - semaglutide, tirzepatide and liraglutide - from the 503B bulk list, a shift that signals broader clinic adoption. Yes, oral semaglutide is increasingly winning over obesity treatment clinics as they look for safer, more convenient, and cost-effective options. Medical Disclaimer: This article is